Your browser doesn't support javascript.
loading
Single-cell multi-omics analysis of the immune response in COVID-19.
Stephenson, Emily; Reynolds, Gary; Botting, Rachel A; Calero-Nieto, Fernando J; Morgan, Michael D; Tuong, Zewen Kelvin; Bach, Karsten; Sungnak, Waradon; Worlock, Kaylee B; Yoshida, Masahiro; Kumasaka, Natsuhiko; Kania, Katarzyna; Engelbert, Justin; Olabi, Bayanne; Spegarova, Jarmila Stremenova; Wilson, Nicola K; Mende, Nicole; Jardine, Laura; Gardner, Louis C S; Goh, Issac; Horsfall, Dave; McGrath, Jim; Webb, Simone; Mather, Michael W; Lindeboom, Rik G H; Dann, Emma; Huang, Ni; Polanski, Krzysztof; Prigmore, Elena; Gothe, Florian; Scott, Jonathan; Payne, Rebecca P; Baker, Kenneth F; Hanrath, Aidan T; Schim van der Loeff, Ina C D; Barr, Andrew S; Sanchez-Gonzalez, Amada; Bergamaschi, Laura; Mescia, Federica; Barnes, Josephine L; Kilich, Eliz; de Wilton, Angus; Saigal, Anita; Saleh, Aarash; Janes, Sam M; Smith, Claire M; Gopee, Nusayhah; Wilson, Caroline; Coupland, Paul; Coxhead, Jonathan M.
Afiliação
  • Stephenson E; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Reynolds G; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Botting RA; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Calero-Nieto FJ; Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Morgan MD; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, UK.
  • Tuong ZK; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Bach K; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Sungnak W; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Worlock KB; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, UK.
  • Yoshida M; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Kumasaka N; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Kania K; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Engelbert J; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Olabi B; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Spegarova JS; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Wilson NK; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Mende N; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Jardine L; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Gardner LCS; Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Goh I; Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Horsfall D; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • McGrath J; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Webb S; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Mather MW; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Lindeboom RGH; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Dann E; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Huang N; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Polanski K; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Prigmore E; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Gothe F; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Scott J; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Payne RP; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Baker KF; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Hanrath AT; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
  • Schim van der Loeff ICD; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Barr AS; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Sanchez-Gonzalez A; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Bergamaschi L; NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Mescia F; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Barnes JL; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation, Newcastle upon Tyne, UK.
  • Kilich E; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • de Wilton A; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation, Newcastle upon Tyne, UK.
  • Saigal A; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation, Newcastle upon Tyne, UK.
  • Saleh A; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.
  • Janes SM; Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Smith CM; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.
  • Gopee N; Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Wilson C; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Coupland P; University College London Hospitals NHS Foundation Trust, London, UK.
  • Coxhead JM; University College London Hospitals NHS Foundation Trust, London, UK.
Nat Med ; 27(5): 904-916, 2021 05.
Article em En | MEDLINE | ID: mdl-33879890
ABSTRACT
Analysis of human blood immune cells provides insights into the coordinated response to viral infections such as severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019 (COVID-19). We performed single-cell transcriptome, surface proteome and T and B lymphocyte antigen receptor analyses of over 780,000 peripheral blood mononuclear cells from a cross-sectional cohort of 130 patients with varying severities of COVID-19. We identified expansion of nonclassical monocytes expressing complement transcripts (CD16+C1QA/B/C+) that sequester platelets and were predicted to replenish the alveolar macrophage pool in COVID-19. Early, uncommitted CD34+ hematopoietic stem/progenitor cells were primed toward megakaryopoiesis, accompanied by expanded megakaryocyte-committed progenitors and increased platelet activation. Clonally expanded CD8+ T cells and an increased ratio of CD8+ effector T cells to effector memory T cells characterized severe disease, while circulating follicular helper T cells accompanied mild disease. We observed a relative loss of IgA2 in symptomatic disease despite an overall expansion of plasmablasts and plasma cells. Our study highlights the coordinated immune response that contributes to COVID-19 pathogenesis and reveals discrete cellular components that can be targeted for therapy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Proteoma / Análise de Célula Única / Transcriptoma / SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Proteoma / Análise de Célula Única / Transcriptoma / SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido